Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases
Authors
Keywords
Parkinson disease, Nrf2, Mitochondrial biogenesis, Mitophagy, Mitochondrial quality control
Journal
NEUROCHEMICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-07
DOI
10.1007/s11064-018-02711-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NFE2L2, PPARGC1α , and pesticides and Parkinson’s disease risk and progression
- (2018) Kimberly C. Paul et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Ameliorating mitochondrial dysfunction restores carbon ion-induced cognitive deficits via co-activation of NRF2 and PINK1 signaling pathway
- (2018) Yang Liu et al. Redox Biology
- Oxidative stress-elicited YY1 potentiates antioxidative response via enhancement of NRF2-driven transcriptional activity: A potential neuronal defensive mechanism against ischemia/reperfusion cerebral injury
- (2018) Wei Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Mitochondria in the pathophysiology of Alzheimer s and Parkinson s diseases
- (2017) Isaac G Onyango Frontiers in Bioscience-Landmark
- Meta-Analysis of Parkinson’s Disease and Alzheimer’s Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes
- (2017) Qian Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Vitamin C and Immune Function
- (2017) Anitra Carr et al. Nutrients
- PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells
- (2017) Hoon-In Choi et al. Scientific Reports
- The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1
- (2017) Li Xiao et al. Redox Biology
- Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
- (2016) Isabel Lastres-Becker et al. ANTIOXIDANTS & REDOX SIGNALING
- Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease
- (2016) M. Ahuja et al. JOURNAL OF NEUROSCIENCE
- The NFE2L2 rs35652124 polymorphism and the risk of Parkinson’s disease
- (2016) Mengru Zhu et al. NEUROREPORT
- NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
- (2016) YaXing Gui et al. Oncotarget
- Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis
- (2016) Marie-Louise Zeissler et al. Oncotarget
- Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
- (2016) Yunes Panahi et al. INFLAMMOPHARMACOLOGY
- Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis
- (2015) Yeonsoo Joe et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants
- (2015) Amir Sarrafchi et al. CURRENT PHARMACEUTICAL DESIGN
- Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity
- (2015) Yi-Hsien Tsou et al. EXPERIMENTAL NEUROLOGY
- The emerging role of Nrf2 in mitochondrial function
- (2015) Albena T. Dinkova-Kostova et al. FREE RADICAL BIOLOGY AND MEDICINE
- Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment
- (2015) Asuka Yasueda et al. INTEGRATIVE CANCER THERAPIES
- The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
- (2015) Michael Lazarou et al. NATURE
- Moderate-Intensity Physical Exercise Protects Against Experimental 6-Hydroxydopamine-Induced Hemiparkinsonism Through Nrf2-Antioxidant Response Element Pathway
- (2015) Aderbal Silva Aguiar et al. NEUROCHEMICAL RESEARCH
- NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions
- (2015) Hitoshi Murata et al. PLoS One
- Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study
- (2014) Malin von Otter et al. BMC Medical Genetics
- PMI: A ΔΨm Independent Pharmacological Regulator of Mitophagy
- (2014) Daniel A. East et al. CHEMISTRY & BIOLOGY
- Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
- (2014) Ning Zhang et al. PLoS One
- Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target
- (2013) N. K. Zenkov et al. BIOCHEMISTRY-MOSCOW
- Punctum on two different transcription factors regulated by PGC-1α: Nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2
- (2013) Sara Baldelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Nrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophy
- (2013) Samantha A Whitman et al. EXPERIMENTAL CELL RESEARCH
- Peroxisome Proliferator-activated Receptor γ Co-activator 1-α as a Critical Co-activator of the Murine Hepatic Oxidative Stress Response and Mitochondrial Biogenesis inStaphylococcus aureusSepsis
- (2013) Anne D. Cherry et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
- (2013) Andreas Puschmann PARKINSONISM & RELATED DISORDERS
- Role of Oxidative Stress in Parkinson's Disease
- (2013) Onyou Hwang Experimental Neurobiology
- Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice
- (2012) Janhavi Athale et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
- (2012) Michael H. Yan et al. FREE RADICAL BIOLOGY AND MEDICINE
- PARK2 variability in Polish Parkinson’s disease patients - interaction with mitochondrial haplogroups
- (2012) Katarzyna Gaweda-Walerych et al. PARKINSONISM & RELATED DISORDERS
- Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease
- (2012) Yi-Chun Chen et al. PARKINSONISM & RELATED DISORDERS
- Interaction of the Transcription Start Site Core Region and Transcription Factor YY1 Determine Ascorbate Transporter SVCT2 Exon 1a Promoter Activity
- (2012) Huan Qiao et al. PLoS One
- Nuclear Control of Respiratory Chain Expression by Nuclear Respiratory Factors and PGC-1-Related Coactivator
- (2010) Richard C. Scarpulla Annals of the New York Academy of Sciences
- Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
- (2010) Malin von Otter et al. BMC Medical Genetics
- p62/SQSTM1Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
- (2010) Ashish Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
- (2010) Sven Geisler et al. NATURE CELL BIOLOGY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Pathogenetic mechanisms in hereditary dysfunctions of complex I of the respiratory chain in neurological diseases
- (2009) Sergio Papa et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2
- (2009) Fiona E. Harrison et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair
- (2009) Oliver Rothfuss et al. HUMAN MOLECULAR GENETICS
- Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1
- (2008) Claude A. Piantadosi et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started